| abstract |
The present invention discloses a novel use of a lanostane having the following formula (I) in treating a disease induced from immune disorder: n n n n n n n n n n wherein R 1 is either H or CH 3 ; R 2 is OCOCH 3 , ═O or OH; R 3 is H or OH; R 4 is —C(═CH 2 )—C(CH 3 ) 2 R a , in which R a is H or OH, or —CH═C(CH 3 )—R b , in which R b is CH 3 or CH 2 OH; R 5 is H or OH; and R 6 is CH 3 or CH 2 OH. |